BARBARA KINKLE: Open Payments
NPI 1104262757 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 85 payments from 9 companies in 2025. Trend: 2023 $1,761 · 2024 $1,627 · 2025 $1,156
Food & beverage: $1,156
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 42 | $558 |
| ABBVIE INC. | 18 | $230 |
| Lilly USA, LLC | 14 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Organon LLC | 3 | $69 |
| UCB, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| LEO Pharma Inc. | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
Products named: TREMFYA, RINVOQ, TALTZ, VTAMA, SKYRIZI, COSENTYX, Rhapsido, Bimzelx.
Industry payments across CA — which companies pay providers there.
